Human/Primate IL-6 Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF206
Key Product Details
Species Reactivity
Validated:
Human, Primate
Cited:
Human, Primate - Papio cynocephalus (Yellow Baboon)
Applications
Validated:
ELISA Detection (Matched Antibody Pair), Immunocytochemistry, Western Blot
Cited:
Antibody Array Development, Array Development, Bioassay, Electrochemiluminescent Assay, ELISA Capture, ELISA Detection, ELISA Development, ELISA Development (Detection), Functional Assay
Label
Biotin
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
E. coli-derived recombinant human IL-6
Pro29-Met212
Accession # P05231
Pro29-Met212
Accession # P05231
Specificity
Detects human and primate IL-6 in ELISAs and Western blots. In sandwich immunoassays, less than 0.1% cross-reactivity with recombinant porcine IL‑6 is observed and less than 0.01% cross-reactivity with recombinant mouse IL-6 and recombinant rat IL-6 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for Human/Primate IL-6 Biotinylated Antibody
IL‑6 in Human PBMCs.
IL-6 was detected in immersion fixed human peripheral blood mononuclear cells (PBMCs) stimulated with LPS and monensin using Human/Primate IL-6 Biotinylated Antigen Affinity-purified Polyclonal Antibody (Catalog # BAF206) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Streptavidin (red; Catalog # NL999) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Non-adherent Cells.Detection of Human IL-6 by Functional
Differences in Functional Profiles between Three Patients with Different Clinical Outcomesgp100 209–2M spots co-spotted with anti-IFN gamma, anti-TNF alpha, anti-IL1b, and anti-IL-6 are shown for three separate patient samples. Patient 10735, who remains free of disease at this writing, displays strong IFN gamma, TNF alpha, IL-1b, and IL-6 secretion. Patients 10710 and 10737 show strong IFN gamma secretion, but weak to no TNF alpha, IL-1b, and IL-6 secretion; both patients experienced disease recurrence soon after these samples were drawn. Note the diffuse pattern of IL-1b and IL-6 capture, which differs from the focal capture of IFN gamma and TNF alpha. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/16162034), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human/Primate IL-6 Biotinylated Antibody
Application
Recommended Usage
Immunocytochemistry
5-15 µg/mL
Sample: Immersion fixed human peripheral blood mononuclear cells stimulated with LPS and monensin
Sample: Immersion fixed human peripheral blood mononuclear cells stimulated with LPS and monensin
Western Blot
0.1 µg/mL
Sample: Recombinant Human IL-6 (Catalog # 206-IL)
Sample: Recombinant Human IL-6 (Catalog # 206-IL)
Human/Primate IL-6 Sandwich Immunoassay
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Reviewed Applications
Read 2 reviews rated 4 using BAF206 in the following applications:
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-6
Long Name
Interleukin 6
Alternate Names
BSF-2, BSF2, IFNB2, IL6, MGI-2A
Entrez Gene IDs
Gene Symbol
IL6
UniProt
Additional IL-6 Products
Product Documents for Human/Primate IL-6 Biotinylated Antibody
Product Specific Notices for Human/Primate IL-6 Biotinylated Antibody
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...